BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Toldo S, Mezzaroma E, Buckley LF, Potere N, Di Nisio M, Biondi-Zoccai G, Van Tassell BW, Abbate A. Targeting the NLRP3 inflammasome in cardiovascular diseases. Pharmacol Ther 2021;236:108053. [PMID: 34906598 DOI: 10.1016/j.pharmthera.2021.108053] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Su X, Liu B, Wang S, Wang Y, Zhang Z, Zhou H, Li F. NLRP3 inflammasome: A potential therapeutic target to minimize renal ischemia/reperfusion injury during transplantation. Transpl Immunol 2022;75:101718. [PMID: 36126906 DOI: 10.1016/j.trim.2022.101718] [Reference Citation Analysis]
2 Dobrev D, Heijman J, Hiram R, Li N, Nattel S. Inflammatory signalling in atrial cardiomyocytes: a novel unifying principle in atrial fibrillation pathophysiology. Nat Rev Cardiol. [DOI: 10.1038/s41569-022-00759-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Ding K, Song C, Hu H, Yin K, Huang H, Tang H, Jakovljevic V. The Role of NLRP3 Inflammasome in Diabetic Cardiomyopathy and Its Therapeutic Implications. Oxidative Medicine and Cellular Longevity 2022;2022:1-19. [DOI: 10.1155/2022/3790721] [Reference Citation Analysis]
4 Mauro AG, Mezzaroma E, Toldo S, Melendez G, Franco RL, Lesnefsky EJ, Abbate A, Hundley WG, Salloum FN. NLRP3-mediated Inflammation in CardioOncology: Sterile yet Harmful. Translational Research 2022. [DOI: 10.1016/j.trsl.2022.08.004] [Reference Citation Analysis]
5 Liao Y, Liu K, Zhu L. Emerging Roles of Inflammasomes in Cardiovascular Diseases. Front Immunol 2022;13:834289. [PMID: 35464402 DOI: 10.3389/fimmu.2022.834289] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
6 Yan J, Ding D, Feng G, Yang Y, Zhou Y, Ma L, Guo H, Lu Z, Jin Q. Metformin reduces chondrocyte pyroptosis in an osteoarthritis mouse model by inhibiting NLRP3 inflammasome activation. Exp Ther Med 2022;23:222. [PMID: 35222699 DOI: 10.3892/etm.2022.11146] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]